NCT06322641CompletedNot Applicable
FLAME-ASCVD-Nephro A Multinational Survey-based Study to Understand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE of hsCRP as a Biomarker in Patients With AtheroSclerotic CardioVascular Disease and Chronic Kidney Disease Among Nephrologists
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 300
- Locations
- 1
- Primary Endpoint
- Nephrologists' perceptions towards the role of systemic inflammation in the identification, treatment and management of patients with ASCVD and CKD
Study Overview
Brief Summary
The purpose of this survey is to collect information for scientific research and to better understand the role of systemic inflammation in identification, treatment and management of patients with Atherosclerotic Cardiovascular Disease (ASCVD) and Chronic Kidney Disease (CKD)
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Cross Sectional
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
- •Male or female, age above or equal to 18 years at the time of signing informed consent.
- •Is a Nephrologist.
- •Has been in practice greater than or equal to 3 years.
- •Sees at least 20 patients with ASCVD and CKD per month.
- •Treats patients for more than only dialysis
Exclusion Criteria
- •Previous participation in this study. Participation is defined as having given informed consent in this study
- •Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
- •Does not meet inclusion criteria requirements
Outcomes
Primary Outcomes
Nephrologists' perceptions towards the role of systemic inflammation in the identification, treatment and management of patients with ASCVD and CKD
Time Frame: At the time of survey response (Day 1)
Multi-select from a defined list; Numerical; A 7-point Likert scale for measurement of agreement from 1 "strongly disagree" to 7 "strongly agree".
Secondary Outcomes
No secondary outcomes reported
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
A Multinational Survey-based Study to Understand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE of hsCRP as a Biomarker in Patients With AtheroSclerotic CardioVascular Disease and Chronic Kidney Disease Among CardiologistsAtherosclerotic Cardiovascular Disease (ASCVD)Chronic Kidney Disease (CKD)NCT05755373Novo Nordisk A/S602
Completed
Not Applicable
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 DiabetesDiabetes Mellitus, Type 2NCT01400971Eli Lilly and Company4,299
Completed
Not Applicable
Multinational Survey of Epidemiology, Morbidity, and Outcomes in Intracerebral HemorrhageIntracerebral HemorrhageNCT02567162The University of Texas Health Science Center at San Antonio40
Completed
Not Applicable
An Observational Study to Collect Information on Safety and to Document the Drug Utilization of Fampyra (BIIB041) When Used In Routine Medical PracticeMultiple SclerosisNCT01480063Biogen4,734
Completed
Not Applicable
Adverse Event Scale in Patients With Epilepsy (aEscape) - A European Survey for Physicians With Epilepsy PatientsEpilepsyNCT00394927UCB Pharma1,000